79 results
8-K
EX-1.1
MREO
Mereo Biopharma Group Plc
14 Jun 24
Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market
4:30pm
of pharmaceuticals or biohazardous substances or materials, including without limitation the U.S. federal Food, Drug and Cosmetic Act, U.S. data privacy … products, asbestos-containing materials or mold (collectively, “Hazardous Materials”) or to the manufacture, processing, distribution, use, treatment
424B5
MREO
Mereo Biopharma Group Plc
14 Jun 24
Prospectus supplement for primary offering
4:15pm
not receive voting materials in time to be able to exercise their right to vote.
Holders of ADSs are not able to exercise voting rights attaching … not receive voting materials in time to instruct the depositary to vote, and it is possible that they, or persons who hold their ADSs through brokers
S-3
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
voting materials in time to enable such Holders to return voting instructions to the depositary in a timely manner.
Fees and Charges
ADS Holders
S-3
EX-1.2
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
and the regulation of pharmaceuticals or biohazardous substances or materials, including without limitation the U.S. federal Food, Drug and Cosmetic Act, U.S … , asbestos-containing materials or mold (collectively, “Hazardous Materials”) or to the manufacture, processing, distribution, use, treatment, storage
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials … materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
MEREO BIOPHARMA GROUP PLC
Registered
10-K
EX-4.2
rif75 6p2vtt2cn7wd
27 Mar 24
Annual report
5:20pm
10-K
iacu ks209bp1
27 Mar 24
Annual report
5:20pm
10-K
EX-10.30
m2vu5k my53u
27 Mar 24
Annual report
5:20pm
6-K
EX-99.2
furjnisd 4x7muo
7 Sep 23
Current report (foreign)
7:37am
6-K
EX-99.2
wlq w2fdgh
2 Nov 22
Current report (foreign)
4:17pm
6-K
EX-99.1
vyp 5fq645lzyo7fqec
21 Oct 22
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
7:06am